A systematic comparison of patient information leaflets from local and multinational pharmaceutical companies: Assessing content quality and completeness

Multinational and local PILs, both performed well in providing basic information on active ingredients, brand names, contraindications, pregnancy, and lactation details. However, disparities among various aspects including inactive ingredient, specific dosing, dose adjusments and drug interactions between PILS of multinational and local pharmaceutical companies in Pakistan highlights the necessity for regulatory measures and industry initiatives to standardize PIL content. For ensuring patient safety and enhancing the quality of medication use it is essential to improve the comprehensiveness and clarity of PILs.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-11-07
DOI
https://doi.org/10.1371/journal.pone.0335149
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A systematic comparison of patient information leaflets from local and multinational pharmaceutical companies: Assessing content quality and completeness

Omar Awad Alsaidan, Azfar Athar Ishaqui, Tauqeer Hussain Mallhi, Sami I. Alzarea et al.
PLoS ONE
Pharmaceutical Quality and Counterfeiting
article

A systematic comparison of patient information leaflets from local and multinational pharmaceutical companies: Assessing content quality and completeness

Omar Awad Alsaidan, Azfar Athar Ishaqui, Tauqeer Hussain Mallhi, Sami I. Alzarea, Abdullah Salah Alanazi, Muhammad Zeeshan, Yusra Habib Khan, Muhammad Salman, Javeria Farooq, Abdulaziz Ibrahim Alzarea, Hassan H. Alhassan, Aseel Awad Alsaidan
article en

Abstract

Multinational and local PILs, both performed well in providing basic information on active ingredients, brand names, contraindications, pregnancy, and lactation details. However, disparities among various aspects including inactive ingredient, specific dosing, dose adjusments and drug interactions between PILS of multinational and local pharmaceutical companies in Pakistan highlights the necessity for regulatory measures and industry initiatives to standardize PIL content. For ensuring patient safety and enhancing the quality of medication use it is essential to improve the comprehensiveness and clarity of PILs.

PLoS ONEVol. 20(11)
St. Gregory's University (US), Lahore College for Women University (PK), Iqra University (PK), University of Karachi (PK), Jouf University (SA), Taylor's University (MY), King Khalid University (SA)
Openalex Percentile: Top 57%
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A systematic comparison of patient information leaflets from local and multinational pharmaceutical companies: Assessing content quality and completeness — Omar Awad Alsaidan, Azfar Athar Ishaqui, et al. · PLoS ONE (2025) | TGRS Research Map | TGRS